These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 17822661)
1. Haptoglobin gene polymorphism in type 2 diabetic patients with and without nephropathy: An Egyptian study. Bessa SS; Hamdy SM; Ali EM Eur J Intern Med; 2007 Oct; 18(6):489-95. PubMed ID: 17822661 [TBL] [Abstract][Full Text] [Related]
2. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus. Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152 [TBL] [Abstract][Full Text] [Related]
3. Urinary tumour necrosis factor-alpha excretion independently correlates with clinical markers of glomerular and tubulointerstitial injury in type 2 diabetic patients. Navarro JF; Mora C; Muros M; García J Nephrol Dial Transplant; 2006 Dec; 21(12):3428-34. PubMed ID: 16935891 [TBL] [Abstract][Full Text] [Related]
4. Association of low-grade inflammation with nephropathy in type 2 diabetic patients: role of elevated CRP-levels and 2 different gene-polymorphisms of proinflammatory cytokines. Abrahamian H; Endler G; Exner M; Mauler H; Raith M; Endler L; Rumpold H; Gerdov M; Mannhalter C; Prager R; Irsigler K; Wagner OF Exp Clin Endocrinol Diabetes; 2007 Jan; 115(1):38-41. PubMed ID: 17286233 [TBL] [Abstract][Full Text] [Related]
5. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients. Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088 [TBL] [Abstract][Full Text] [Related]
6. Haptoglobin phenotype and diabetic nephropathy. Nakhoul FM; Zoabi R; Kanter Y; Zoabi M; Skorecki K; Hochberg I; Leibu R; Miller B; Levy AP Diabetologia; 2001 May; 44(5):602-4. PubMed ID: 11380078 [TBL] [Abstract][Full Text] [Related]
7. Manganese superoxide dismutase gene polymorphism (V16A) is associated with stages of albuminuria in Korean type 2 diabetic patients. Lee SJ; Choi MG; Kim DS; Kim TW Metabolism; 2006 Jan; 55(1):1-7. PubMed ID: 16324912 [TBL] [Abstract][Full Text] [Related]
8. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy. Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142 [TBL] [Abstract][Full Text] [Related]
9. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH; Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990 [TBL] [Abstract][Full Text] [Related]
10. Serum and urinary type IV collagen concentrations in the assessment of diabetic microangiopathy. Banu N; Hara H; Egusa G; Yamakido M Hiroshima J Med Sci; 1994 Dec; 43(4):123-33. PubMed ID: 7883578 [TBL] [Abstract][Full Text] [Related]
11. Inflammatory markers and haptoglobin polymorphism in Saudi with non-insulin-dependent diabetes mellitus. Mohieldein A; Alzohairy M; Hasan M; Khan AA Glob J Health Sci; 2012 Nov; 5(1):135-42. PubMed ID: 23283045 [TBL] [Abstract][Full Text] [Related]
12. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients. Takebayashi K; Matsumoto S; Aso Y; Inukai T J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838 [TBL] [Abstract][Full Text] [Related]
13. Association between serum fibroblast growth factor 21 and diabetic nephropathy. Jian WX; Peng WH; Jin J; Chen XR; Fang WJ; Wang WX; Qin L; Dong Y; Su Q Metabolism; 2012 Jun; 61(6):853-9. PubMed ID: 22136913 [TBL] [Abstract][Full Text] [Related]
14. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients. El-Din Bessa SS; Hamdy SM Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353 [TBL] [Abstract][Full Text] [Related]
15. Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus. Wang QY; Chen FQ Diabetes Res Clin Pract; 2009 Feb; 83(2):215-9. PubMed ID: 19097668 [TBL] [Abstract][Full Text] [Related]
16. Polymorphism of the aldosterone synthase gene is not associated with progression of diabetic nephropathy, but associated with hypertension in type 2 diabetic patients. Ko GJ; Kang YS; Lee MH; Song HK; Kim HK; Cha DR Nephrology (Carlton); 2008 Dec; 13(6):492-9. PubMed ID: 18771471 [TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients. Lajer M; Tarnow L; Jorsal A; Parving HH Nephrol Dial Transplant; 2007 Nov; 22(11):3235-9. PubMed ID: 17567649 [TBL] [Abstract][Full Text] [Related]
18. Association of haptoglobin phenotypes with ceruloplasmin ferroxidase activity in β-thalassemia major. Awadallah SM; Nimer NA; Atoum MF; Saleh SA Clin Chim Acta; 2011 May; 412(11-12):975-9. PubMed ID: 21315066 [TBL] [Abstract][Full Text] [Related]
19. [High-sensitive C-reactive protein and Type 2 diabetic nephropathy]. Liao L; Lei MX; Chen HL; Wu J; Guo LJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):627-30. PubMed ID: 16114543 [TBL] [Abstract][Full Text] [Related]
20. Increased serum levels of interleukin-18 in patients with diabetic nephropathy. Mahmoud RA; el-Ezz SA; Hegazy AS Ital J Biochem; 2004 Jul; 53(2):73-81. PubMed ID: 15646011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]